Sign in / Join Now
ETFs & Funds
crossed $52, breached previous high. $58 just in the cards.
Add a reply...
Latest StockTalks »
people get CPHD breaking news and analysis by email alert.
Get email alerts on CPHD »
Get latest price
From other sites
30 Minute Or Less Molecular Flu/RSV Test Now Available Outside The US
at TheStreet (Oct 27, 2016)
Cepheid Announces Receipt Of Required Regulatory Clearances In Proposed Acquisition By Danaher Corporation
at TheStreet (Oct 24, 2016)
Cepheid: Commercial Launch of Xpert Bladder Cancer Monitor
at Zacks.com (Oct 10, 2016)
New Bladder Cancer Test Could Reduce Number Of Invasive Procedures Required For Recurrence Monitoring
at TheStreet (Oct 5, 2016)
Cepheid Announces Expansion of Molecular C. Difficile Product
at Zacks.com (Sep 16, 2016)